Journal
CLINICAL KIDNEY JOURNAL
Volume 14, Issue -, Pages 6-13Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfab023
Keywords
COVID-19; ESRD; haemodialysis; home dialysis; peritoneal dialysis
Categories
Funding
- Fresenius Medical Care
Ask authors/readers for more resources
Patients with advanced CKD are at higher risk of contracting severe infections, making remote management essential during the COVID-19 pandemic.
The novel coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic in March 2020 by the World Health Organization. Older individuals and patients with comorbid conditions such as hypertension, heart disease, diabetes, lung disease, chronic kidney disease (CKD) and immunologic diseases are at higher risk of contracting this severe infection. In particular, patients with advanced CKD constitute a vulnerable population and a challenge in the prevention and control of the disease. Home-based renal replacement therapies offer an opportunity to manage patients remotely, thus reducing the likelihood of infection due to direct human interaction. Patients are seen less frequently, limiting the close interaction between patients and healthcare workers who may contract and spread the disease. However, while home dialysis is a reasonable choice at this time due to the advantage of isolation of patients, measures must be assured to implement the program. Despite its logistical benefits, outpatient haemodialysis also presents certain challenges during times of crises such as the coronavirus disease 2019 (COVID-19) pandemic and potentially future ones.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available